Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index; 20 of the 65 sources its claims cite were checked for support.

Effects of l-theanine–caffeine combination on sustained attention and inhibitory control among children with ADHD: a proof-of-concept neuroimaging RCT

Open access

Abstract

We examined the acute effects of l-theanine, caffeine and their combination on sustained attention, inhibitory control and overall cognition in boys with attention deficit hyperactivity disorder (ADHD). l-Theanine (2.5 mg/kg), caffeine (2.0 mg/kg), their combination and a placebo were administered in a randomized four-way repeated-measures crossover with washout, to five boys (8–15 years) with ADHD. Functional magnetic resonance imaging (fMRI) was performed during a Go/NoGo task and a Stop-signal task ~ 1 h post-dose. NIH Cognition Toolbox was administered ~ 2 h post-dose. Treatment vs. placebo effects were examined in multi-level mixed-effects models. l-Theanine improved total cognition composite in NIH Cognition Toolbox (p = 0.040) vs. placebo. Caffeine worsened and l-theanine had a trend of worsening inhibitory control (i.e. increased Stop-signal reaction time; p = 0.031 and p = 0.053 respectively). l-Theanine–caffeine combination improved total cognition composite (p = 0.041), d-prime in the Go/NoGo task (p = 0.033) and showed a trend of improvement of inhibitory control (p = 0.080). l-Theanine–caffeine combination was associated with decreased task-related reactivity of a brain network associated with mind wandering (i.e. default mode network). l-Theanine–caffeine combination may be a potential therapeutic option for ADHD-associated impairments in sustained attention, inhibitory control and overall cognitive performance.

Overview

CoChat Summary

TL;DR

In a proof-of-concept randomized crossover fMRI trial in five boys with ADHD, acute l-theanine–caffeine combination improved overall cognition and sustained attention, with a trend toward improved inhibitory control. The combination also reduced task-related default mode network reactivity, suggesting decreased mind wandering.

Key findings

  • l-Theanine improved NIH Cognition Toolbox total cognition composite vs placebo by 11.5 points (p = 0.040, d = 1.041); the l-theanine–caffeine combination improved it by 11.4 points (p = 0.041, d = 1.034).
  • The combination improved Go/NoGo d-prime (β = 0.65, p = 0.033, d = 1.077) and showed a trend toward improved inhibitory control via reduced Stop-signal reaction time (β = −0.04, p = 0.080, d = 0.894).
  • Caffeine worsened inhibitory control (increased Stop-signal reaction time, β = 0.05, p = 0.031), and l-theanine showed a trend of worsening it (β = 0.04, p = 0.053).
  • l-Theanine, caffeine, and their combination all improved Go/NoGo hit rate (p < 0.001 for each vs placebo); l-theanine and caffeine decreased posterior DMN reactivity during Go/NoGo (p = 0.034 and p = 0.026), and the combination decreased DMN and CEN reactivity during Stop-signal response inhibition (p = 0.002 and p = 0.007).

Methods

  • Randomized, placebo-controlled, four-way repeated-measures crossover with washout; five male children with ADHD completed the study (mean age 11.87 ± 2.26 years; 20 total measurements per outcome).
  • Doses were 2.5 mg/kg l-theanine, 2.0 mg/kg caffeine, their combination, or placebo; fMRI was performed during Go/NoGo and Stop-signal tasks ~1 h post-dose, and NIH Cognition Toolbox was administered ~2 h post-dose.
  • Behavioral outcomes were analyzed with two-level mixed-effects models (visits nested within subjects), controlling for testing visit; fMRI contrasts were compared against placebo within DMN and CEN using permutation-based cluster thresholding.

Limitations

  • The paper states the study was underpowered to detect significant inhibitory-control improvement with the combination, had a small sample, included only male children with ADHD who responded to stimulants, had broad age and BMI ranges, used single/partial blinding, and could not fully rule out practice, diet/hunger, or cerebrovascular effects.
  • The text also notes data collection ended due to expiration of funding, and one consented participant declined before the first test dose, leaving only five completers.
  • The authors state the preliminary results are not sufficient to generalize benefits to all children with ADHD and require replication in larger controlled trials.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41598-020-70037-7

Cites

87 of 87 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Data collection protocol.
Figure 1 Data collection protocol.CC BY · PubMed Central
Figure 2 CONSORT diagram outlining the details of participant screening, recruitment and completion of data collection.
Figure 2 CONSORT diagram outlining the details of participant screening, recruitment and completion of data collection.CC BY · PubMed Central
Figure 3 Brain regions that showed significant task-related fMRI reactivity following administration of l-theanine, caffeine and their combination vs. placebo, controlling for the testing visit to account for practice effect (N = 5, four repeated measurements per participant; 20 total measurements per outcome). (a) A cluster within DMN showing significant decreased reactivity when exposed to correctly responded Go stimuli in the Go/NoGo task following intake of l-theanine vs. placebo. (b) A cluster within DMN showing significant decreased reactivity when exposed to correctly responded Go stimuli in the Go/NoGo task following intake of caffeine vs. placebo. (c) A cluster within DMN showing significant decreased reactivity during response inhibition while engaged in the Stop-signal reaction task following intake of l-theanine vs. placebo. (d) A cluster within DMN showing significant decreased reactivity during response inhibition while engaged in the Stop-signal reaction task following intake of caffeine vs. placebo. (e) A cluster within DMN showing significant decreased reactivity during response inhibition while engaged in the Stop-signal reaction task following intake of the combination of l-theanine and caffeine vs. placebo. (f) A cluster within CEN showing significant decreased reactivity during response inhibition while engaged in the Stop-signal reaction task following intake of the combination of l-theanine and caffeine vs. placebo. (g) DMN default mode network, CEN central executive network.
Figure 3 Brain regions that showed significant task-related fMRI reactivity following administration of l-theanine, caffeine and their combination vs. placebo, controlling for the testing visit to account for practice effect (N = 5, four repeated measurements per participant; 20 total measurements per outcome). (a) A cluster within DMN showing significant decreased reactivity when exposed to correctly responded Go stimuli in the Go/NoGo task following intake of l-theanine vs. placebo. (b) A cluster within DMN showing significant decreased reactivity when exposed to correctly responded Go stimuli in the Go/NoGo task following intake of caffeine vs. placebo. (c) A cluster within DMN showing significant decreased reactivity during response inhibition while engaged in the Stop-signal reaction task following intake of l-theanine vs. placebo. (d) A cluster within DMN showing significant decreased reactivity during response inhibition while engaged in the Stop-signal reaction task following intake of caffeine vs. placebo. (e) A cluster within DMN showing significant decreased reactivity during response inhibition while engaged in the Stop-signal reaction task following intake of the combination of l-theanine and caffeine vs. placebo. (f) A cluster within CEN showing significant decreased reactivity during response inhibition while engaged in the Stop-signal reaction task following intake of the combination of l-theanine and caffeine vs. placebo. (g) DMN default mode network, CEN central executive network.CC BY · PubMed Central

Verification

Claims the paper makes

12 Valid · 3 Not valid · 17 Not checked · 80 Own results and interpretations

66 more claims · 2 with their cited sources checked

Create a free account to see all 112 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 27
  • It may state two separate claims as one. 21
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 87 references

Research works printed but not linked: 2

  1. Hechtman, L. Considerations in selecting pharmacological treatments for attention deficit hyperactivity disorder. Acute Pain 10, 00 (2019).
  2. Rorden, C. dcm2nii DICOM to NIfTI conversion (MRIcoron, The source for neuroimaging, 2009).

Cited by

See all 45

Metadata

Authors
Kahathuduwa, C. N., Wakefield, S., West, B. D., Blume, J., Dassanayake, T. L., Weerasinghe, V. S., & Mastergeorge, A.
Affiliations
  • Texas Tech University (US)
  • University of Peradeniya (LK)
Corresponding author
Kahathuduwa, Chanaka N.
Venue
Scientific Reports
Published
2020-08-04
Volume
10
Issue
1
Pages
13072-13072
ISSN
2045-2322 (ISSN-L)
OpenAlex
W3047333498
Cited by
45
References
87
Citations by year
2026: 8 · 2025: 11 · 2024: 11 · 2023: 6 · 2022: 5 · 2021: 4
FWCI
2.50
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Figshare (submittedVersion, cc-by)
  • ThinkTech (Texas Tech University) (submittedVersion, cc-by)
  • NOVA (University of Newcastle Australia) (submittedVersion, cc-by)
Funders
  • Texas Tech Neuroimaging Institute
  • Texas Tech University Health Sciences Center - School of Health Professions
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Health Sciences › Medicine › Pharmacology (medical) › Coffee research and impacts
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
theanine, caffeine, attention deficit hyperactivity disorder, sustained attention, inhibitory control, children, go/no-go task, stop-signal task, default mode network, mind wandering, cognitive performance, neuroimaging
MeSH terms
Adolescent, Attention, Attention Deficit Disorder with Hyperactivity, Brain, Caffeine, Child, Cognition, Drug Interactions, Female, Glutamates, Humans, Inhibition, Psychological, Magnetic Resonance Imaging, Male, Neuroimaging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of l-theanine–caffeine combination on sustained attention and inhibitory control among children with ADHD: a proof-of-concept neuroimaging RCT. https://app.cochat.ai/papers/10.1038/s41598-020-70037-7
The paper
Kahathuduwa, C. N., Wakefield, S., West, B. D., Blume, J., Dassanayake, T. L., Weerasinghe, V. S., & Mastergeorge, A. (2020). Effects of l-theanine–caffeine combination on sustained attention and inhibitory control among children with ADHD: a proof-of-concept neuroimaging RCT. Scientific Reports. https://doi.org/10.1038/s41598-020-70037-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.